Background
CD4 counts guide antiretroviral therapy (ART) initiation and prophylaxis for opportunistic infections. It is unclear whether normal CD4 counts translate to normalized immune responses among ART-treated adults. We compared antigen-specific CD4 T-cell immune responses among ART-treated adults with CD4 ≥ 500 cells/μl, optimal immune responders (O-IR), and their age-matched healthy HIV-negative counterparts.
Methods
In a sample-based case–control study, cryopreserved peripheral blood mononuclear cells from 15 O-IR after 7 years of ART and 15 healthy controls, were analyzed for CD4+ T-cell proliferation using CFSE dye and cytokine production.
Results
CD4 T-cell proliferation, upon stimulation with PPD and pneumococcal polysaccharide antigen, was lower among O-IR relative to HIV-negative controls; p = 0.016 and p = 0.016 respectively. CD4 T-cell production of IL-2 was lower among O-IR relative to HIV-negative control p = 0.002. CD4 T-cell proliferation upon stimulation with SEB and CMV antigens was similar among O-IR and HIV-negative controls p = 0.971 and p = 0.480, respectively, and so was IL-4 and IFN γ production; p = 0.528 and p = 0.892, respectively.
Conclusion
Seven years of suppressive ART caused partial CD4 T-cell function recovery in an African HIV treatment cohort, despite restoration of CD4 T-cell counts to levels ≥ 500 cells/μl. The role innate immunity in the recovery of immune function during long-term ART should be investigated to guide decisions on continued prophylaxis against opportunistic infections.